GelStat Corporation (GSAC)

[greenlife]

THE COMPANY GENERATED RECORD REVENUE OF $750,218 FOR THE FOURTH QUARTER ENDED DECEMBER 31, 2014 AND RECORD REVENUE OF $1,312,675 FOR THE FULL YEAR ENDED DECEMBER 31, 2014

PALM CITY, FL -- (Marketwired) -- 04/16/15 -- GelStat Corporation (OTC PINK: GSAC), a fully integrated consumer healthcare company engaged in the development, marketing, branding and manufacturing of innovative over-the-counter (OTC) consumer healthcare products, today reported fourth quarter and year end results.

2014 was a very productive year for GelStat as it significantly increased its operations and capabilities through the acquisition of Mastix Medica. The Company now has an established foundation to build upon as well as key manufacturing capabilities and intellectual property.

Highlights for the 4th Quarter Ended December 31, 2014:

Generated revenue of $750,218 up 38% from $542,477 in the prior quarter.
Net Losses were $178,805 down 61% from $457,935 in the prior quarter.
Highlights for the Full Year Ended December 31, 2014:

Generated revenue of $1,312,675.
Generated gross profit of $221,860.
Completed the acquisition of Mastix Medica, LLC.
Signed distribution agreements with Windmill Health Products and Next Distributors, LLC.
Initiated clinical studies on the effects of Cannabidiol (CBD) infused hemp oil products and CBD oil on pain and inflamed tissue with two recognized experts in their field. Preliminary evidence looks very promising.